Graphene Manufacturing Group Announces Closing of $3.47M Marketed Offering, Including Exercise In Full of the Over-Allotment Option

In This Article:

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

BRISBANE, Australia, May 07, 2024 (GLOBE NEWSWIRE) -- Graphene Manufacturing Group Ltd. (TSX-V: GMG) (“GMG” or the “Company”) is pleased to announce that the Company has closed its previously announced marketed public offering of units (the “Units”) of the Company, including exercise in full of the over-allotment option (the “Offering”). A total of 8,280,000 Units were sold at a price of C$0.42 per Unit for gross proceeds of approximately C$3.47 million. Each Unit is comprised of one ordinary share of the Company (each, an “Ordinary Share”) and one ordinary share purchase warrant (each, a “Warrant”). Each Warrant shall entitle the holder to purchase one ordinary share of the Company (a “Warrant Share”) at an exercise price of C$0.55 per Warrant Share at any time until May 7, 2028, subject to adjustment in certain events. The Offering was completed pursuant to an underwriting agreement dated April 30, 2024 between the Company and Ventum Financial Corp. (formerly PI Financial Corp.) (the “Underwriter”).

The net proceeds of the Offering are expected to be used primarily to strengthen the Company's financial position and provide liquidity to ?finance ongoing operations, including, in particular, the Company’s expenses incurred, and expected to be ?incurred, in connection with the Company’s research and development objectives, and for working capital and general corporate purposes.

In connection with the Offering, the Company paid the Underwriter a cash commission equal to 7% of the gross proceeds of the Offering and issued to the Underwriter such number of compensation warrants as is equal to 7% of the number of Units sold pursuant to the Offering (the “Compensation Warrants”). Each Compensation Warrant is exercisable into a Unit at an exercise price of C$0.42 per Unit until May 7, 2028.

The Offering was completed pursuant to a prospectus supplement dated April 30, 2024 (the “Supplement”) to the Company’s amended and restated base shelf prospectus receipted on January 10, 2024 (the "Base Shelf Prospectus"). Copies of the Supplement and the Base Shelf Prospectus can be obtained on SEDAR + at www.sedarplus.ca.

The TSX Venture Exchange (“TSXV”) has conditionally approved the listing of the Ordinary Shares. The Company does not intend to list the Warrants for trading.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the United States Securities Act of 1933, as amended, and applicable state securities laws.